FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306957250> ?p ?o ?g. }

• W4306957250 abstract "Article Tools CASE REPORTS Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/PO.22.00349 JCO Precision Oncology no. 6 (2022) e2200349. Published online October 20, 2022. PMID: 36265117 Germline SMARCA4 Deletion as a Driver of Uterine Cancer: An Atypical Presentation Anastasia Navitski , MD1xAnastasia NavitskiSearch for articles by this author; Duaa H. Al-Rawi , MD, PhD2xDuaa H. Al-RawiSearch for articles by this author; Vicky Makker , MD2,3xVicky MakkerSearch for articles by this author; Britta Weigelt , MD4xBritta WeigeltSearch for articles by this author; Dmitriy Zamarin , MD, PhD2,3xDmitriy ZamarinSearch for articles by this author; Ying Liu , MD, MPH2,3,5xYing LiuSearch for articles by this author; Angela G. Arnold , MS5xAngela G. ArnoldSearch for articles by this author; M. Herman Chui , MD4xM. Herman ChuiSearch for articles by this author; Diana L. Mandelker , MD, PhD4xDiana L. MandelkerSearch for articles by this author; Michael Walsh , MD5xMichael WalshSearch for articles by this author; Deborah F. DeLair, MD6xDeborah F. DeLairSearch for articles by this author; Karen A. Cadoo , MD7xKaren A. CadooSearch for articles by this author; and Roisin E. O'Cearbhaill, MD2,3xRoisin E. O'CearbhaillSearch for articles by this author Show More 1Department of Obstetrics and Gynecology, Augusta University, Augusta, GA2Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY3Department of Medicine, Weill Cornell Medical College, New York, NY4Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY5Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY6Department of Pathology, New York University, New York, NY7St James's Hospital, Trinity College Dublin, Trinity St James's Cancer Institute, Dublin, Ireland https://doi.org/10.1200/PO.22.00349 First Page Full Text PDF Figures and Tables © 2022 by American Society of Clinical OncologySUPPORTSupported in part by the NIH/NCI Cancer Center Support Grant P30 CA008748.AUTHOR CONTRIBUTIONSConception and design: Anastasia Navitski, Karen A. Cadoo, Roisin E. O'CearbhaillProvision of study materials or patients: Duaa H. Al-Rawi, Karen A. CadooCollection and assembly of data: Anastasia Navitski, Duaa H. Al-Rawi, Angela G. Arnold, Diana L. Mandelker, Deborah F. DeLair, Karen A. Cadoo, Roisin E. O'CearbhaillData analysis and interpretation: Anastasia Navitski, Duaa H .Al-Rawi, Vicky Makker, Britta Weigelt, Dmitriy Zamarin, Ying Liu, M Herman Chui, Diana L. Mandelker, Michael Walsh, Deborah F. DeLair, Karen A. Cadoo, Roisin E. O'CearbhaillManuscript writing: All authorsFinal approval of manuscript: All authorsAccountable for all aspects of the work: All authorsAUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTERESTThe following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/po/author-center.Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).Vicky MakkerConsulting or Advisory Role: Eisai, Merck, Karyopharm Therapeutics, Takeda, ArQule, IBM, GlaxoSmithKline, Clovis Oncology, Faeth Therapeutics, Novartis, Duality, iTeos Therapeutics, Kartos Therapeutics, LillyResearch Funding: Lilly (Inst), AstraZeneca (Inst), Eisai (Inst), Merck (Inst), Bristol-Myers Squibb (Inst), Karyopharm Therapeutics (Inst), Takeda (Inst), Clovis Oncology (Inst), Bayer (Inst), Zymeworks (Inst), Duality (Inst), Faeth Therapeutics (Inst)Travel, Accommodations, Expenses: Eisai, Merck, Karyopharm TherapeuticsOther Relationship: IBMBritta WeigeltStock and Other Ownership Interests: Repare TherapeuticsConsulting or Advisory Role: Ventana Medical Systems, Volition RX, PAIGE, Goldman Sachs, Repare Therapeutics, LillyDmitriy ZamarinStock and Other Ownership Interests: ImmunOs Therapeutics, Calidi Biotherapeutics, AccuriusConsulting or Advisory Role: Synlogic, Agenus, Genentech/Roche, Memgen, Celldex, AstraZeneca, Crown Bioscience, Synthekine, GlaxoSmithKline, Hookipa Biotech, Tessa Therapeutics, Xencor, TargovaxResearch Funding: AstraZeneca/MedImmune (Inst), Genentech (Inst), Plexxikon (Inst), Bristol-Myers Squibb (Inst), Synthekine (Inst)Patents, Royalties, Other Intellectual Property: I hold a patent regarding the use of recombinant Newcastle Disease Virus (NDV) for cancer therapy (Inst)Ying LiuResearch Funding: AstraZeneca (Inst), Tesaro/GSK (Inst), Repare Therapeutics (Inst)Travel, Accommodations, Expenses: AstraZenecaAngela G. ArnoldStock and Other Ownership Interests: Crispr Therapeutics, AbbVie, Becton Dickinson, Dexcom, Gilead Sciences, PfizerM. Herman ChuiHonoraria: Roche Pharma AGResearch Funding: Paige A.IKaren A. CadooHonoraria: Pfizer, Roche IrelandConsulting or Advisory Role: Astra Zeneca, MJH Life Sciences, MSD Ireland, GSK Ireland, NextCureResearch Funding: MSD (Inst), Immunogen (Inst)Roisin E. O'CearbhaillHonoraria: GlaxoSmithKline, Curio Science, MJH Life SciencesConsulting or Advisory Role: Seagan, Aptitude Health, Fresenius Kabi, GlaxoSmithKline, Bayer, Regeneron, Carina Biotech, Immunogen, R-Pharm, GOG FoundationResearch Funding: Juno Therapeutics (Inst), Sellas Life Sciences (Inst), Ludwig Institute for Cancer Research (Inst), Stemcentrx (Inst), TapImmune Inc (Inst), TCR2 Therapeutics (Inst), Regeneron (Inst), Genmab (Inst), Atara Biotherapeutics (Inst), GlaxoSmithKline (Inst), AstraZeneca/Merck (Inst), Syndax (Inst), Genentech (Inst), Kite/Gilead (Inst), GOG Foundation (Inst), Merck/Genentech (Inst), Bayer (Inst)Travel, Accommodations, Expenses: Hitech HealthOther Relationship: JAMA OncologyUncompensated Relationships: CMRFOpen Payments Link: https://openpaymentsdata.cms.gov/physician/785539No other potential conflicts of interest were reported." @default.
• W4306957250 created "2022-10-21" @default.
• W4306957250 creator A5012395487 @default.
• W4306957250 creator A5015952679 @default.
• W4306957250 creator A5024030367 @default.
• W4306957250 creator A5026953370 @default.
• W4306957250 creator A5029101674 @default.
• W4306957250 creator A5040506127 @default.
• W4306957250 creator A5050336579 @default.
• W4306957250 creator A5053852463 @default.
• W4306957250 creator A5059048867 @default.
• W4306957250 creator A5062778506 @default.
• W4306957250 creator A5074877517 @default.
• W4306957250 creator A5081993288 @default.
• W4306957250 creator A5085163128 @default.
• W4306957250 date "2022-10-01" @default.
• W4306957250 modified "2023-10-03" @default.
• W4306957250 title "Germline <i>SMARCA4</i> Deletion as a Driver of Uterine Cancer: An Atypical Presentation" @default.
• W4306957250 cites W1464973783 @default.
• W4306957250 cites W1566837890 @default.
• W4306957250 cites W1941960325 @default.
• W4306957250 cites W1969528294 @default.
• W4306957250 cites W1979256255 @default.
• W4306957250 cites W1981091031 @default.
• W4306957250 cites W1992627864 @default.
• W4306957250 cites W2001416462 @default.
• W4306957250 cites W2002218976 @default.
• W4306957250 cites W2016991737 @default.
• W4306957250 cites W2022093187 @default.
• W4306957250 cites W2031692395 @default.
• W4306957250 cites W2051128686 @default.
• W4306957250 cites W2051978340 @default.
• W4306957250 cites W2059154675 @default.
• W4306957250 cites W2087436342 @default.
• W4306957250 cites W2114058467 @default.
• W4306957250 cites W2119079421 @default.
• W4306957250 cites W2127034693 @default.
• W4306957250 cites W223909586 @default.
• W4306957250 cites W2253928581 @default.
• W4306957250 cites W2300491315 @default.
• W4306957250 cites W2339799578 @default.
• W4306957250 cites W2342043466 @default.
• W4306957250 cites W2460529418 @default.
• W4306957250 cites W2539053995 @default.
• W4306957250 cites W2574827531 @default.
• W4306957250 cites W2581504178 @default.
• W4306957250 cites W2591968025 @default.
• W4306957250 cites W2603189030 @default.
• W4306957250 cites W2607808741 @default.
• W4306957250 cites W2613362156 @default.
• W4306957250 cites W2726357279 @default.
• W4306957250 cites W2801965474 @default.
• W4306957250 cites W2805660084 @default.
• W4306957250 cites W2810269595 @default.
• W4306957250 cites W2890293509 @default.
• W4306957250 cites W2895183267 @default.
• W4306957250 cites W2896753349 @default.
• W4306957250 cites W2911595146 @default.
• W4306957250 cites W2915022564 @default.
• W4306957250 cites W2921804231 @default.
• W4306957250 cites W2940105435 @default.
• W4306957250 cites W2940975864 @default.
• W4306957250 cites W2942073349 @default.
• W4306957250 cites W2945474619 @default.
• W4306957250 cites W2949760369 @default.
• W4306957250 cites W2953124185 @default.
• W4306957250 cites W2953307540 @default.
• W4306957250 cites W2973979439 @default.
• W4306957250 cites W2980545322 @default.
• W4306957250 cites W2989724722 @default.
• W4306957250 cites W2999261939 @default.
• W4306957250 cites W3011022719 @default.
• W4306957250 cites W3016075177 @default.
• W4306957250 cites W3016379099 @default.
• W4306957250 cites W3022047171 @default.
• W4306957250 cites W3025031060 @default.
• W4306957250 cites W3038027381 @default.
• W4306957250 cites W3042042036 @default.
• W4306957250 cites W3110468326 @default.
• W4306957250 cites W3160571440 @default.
• W4306957250 cites W3179393623 @default.
• W4306957250 cites W4226221708 @default.
• W4306957250 doi "https://doi.org/10.1200/po.22.00349" @default.
• W4306957250 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36265117" @default.
• W4306957250 hasPublicationYear "2022" @default.
• W4306957250 type Work @default.
• W4306957250 citedByCount "2" @default.
• W4306957250 countsByYear W43069572502023 @default.
• W4306957250 crossrefType "journal-article" @default.
• W4306957250 hasAuthorship W4306957250A5012395487 @default.
• W4306957250 hasAuthorship W4306957250A5015952679 @default.
• W4306957250 hasAuthorship W4306957250A5024030367 @default.
• W4306957250 hasAuthorship W4306957250A5026953370 @default.
• W4306957250 hasAuthorship W4306957250A5029101674 @default.
• W4306957250 hasAuthorship W4306957250A5040506127 @default.
• W4306957250 hasAuthorship W4306957250A5050336579 @default.
• W4306957250 hasAuthorship W4306957250A5053852463 @default.
• W4306957250 hasAuthorship W4306957250A5059048867 @default.
• W4306957250 hasAuthorship W4306957250A5062778506 @default.
• W4306957250 hasAuthorship W4306957250A5074877517 @default.

• next